Skip to Content

Eastman Chemical Co EMN

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Raising Eastman FVE to $96 on Higher Growth Outlook; Shares Fairly Valued

Seth Goldstein, CFA Senior Equity Analyst

Analyst Note

| Seth Goldstein, CFA |

Eastman's fourth-quarter results showed the company's businesses are recovering from the coronavirus-related economic slowdown. Operating earnings were up around 18% year on year during the quarter, led by growth in the company's two main segments: advanced materials and additives and functional products. Management expects the recovery to continue in 2021, guiding to adjusted EPS growth of 20%-30% for the year. We see continued recovery in all segments and think the guidance is achievable albeit at the lower end of the range. 

Read Full Analysis

Company Profile

Business Description

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemicals with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

Contact
200 South Wilcox Drive
Kingsport, TN, 37662
T +1 423 229-2000
Sector Basic Materials
Industry Chemicals
Most Recent Earnings Dec 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type Cyclical
Employees 14,500

Related